Confirmed on the employer's own hiring board on Oct 9, 2026. First seen by Alion on Oct 9, 2026. AstraZeneca scores A on the Alion truth index.
Are you ready to dive into the world of transformative therapies and make a significant impact? At EsoBiotec, now part of AstraZeneca, we are setting new benchmarks for biotechnological research. Our collaboration combines AstraZeneca’s global influence and scientific innovation with EsoBiotec’ s unique culture of creativity and breakthroughs in cell-based therapies and immunology. Here, your scientific passion will drive real-world impact as you contribute to life-changing treatments. We are looking for an inspiring Senior Scientist Vector Engineering to drive innovation and development of our pioneering lentiviral vector therapeutic platform. Join us in shaping the future of cell and gene therapy with your expertisein viral vector engineering, gene editing, CARand TCR T cell engineering or myeloid immunobiology in cancer. You will report to theAssociate Director In Vivo Cell Therapy and be based in Cambridge, MA.
Responsibilities
Design, build, and validatenovel lentiviral vectors for invivo cell therapy applications.
Perform hands-on construct designs, viral genome optimization, viral envelope pseudotypeengineering and vector assembly.
Design, planand execute in vitro and in vivo experiments to assess transduction efficiency, specificity, expression durability, and safety profile of novel in vivo LVVs.
Develop and run assays for titer, potency, biodistribution, integrationsite analysis, and immunogenicity in collaboration with analytics partners.
Apply literature mining, public datasets, and personal expertiseto generate innovative, testable hypotheses and prioritize vector concepts.
Implement rigorous experimental design, statistical analysis, and documentation to ensure reproducibility, traceability, and data integrity.
Collaborate extensively with discovery teams across AZ including payload biology, bioinformatics, and nonclinical to align vector designs with product requirements.
Contribute to platform development by creating screening workflows, model systems, and standardized protocols for vector performance.
Present findings, risks, and recommendations in working groups and project meetings and drive decisions through clear data storytelling.
Support IP generation by contributing to invention disclosures and sharing FTO considerations with the IP team.
Essential Skills/Experience
PhD in molecular biology, virology, bioengineering, or related field with 2+ years of postdoctoral experience in academia or industry.
Demonstrated expertisein viral vectors and virology with a strong track recordin viral vector design, engineering, and characterization for gene therapy
Proficiencyin molecular biology techniques for vector construction, promoter and regulatory element engineering, and payload optimization.
Experience in protein and antibody (scFVand VHH) engineering or envelope/pseudotypemodification to tune tropism, entry, and transduction profiles.
Hands-on familiarity with in vitro cell culture assays and in vivo models for vector evaluation including transduction assays, dose-response, durability studies, and safety readouts.
Strong hands-on competence with quantitative analytics such as flow cytometry and qPCR/ddPCR.
Ability to design rigorous experiments, apply statistics, and interpret complex datasets to drive go/no-go decisions.
Strong collaboration and communication skills to operateas a backbone member of cross-functional working groups and align discovery efforts with product goals.
Evidence of innovation through publications, presentations, or open-source contributions and comfort leveragingliterature and public data to ideateand de-risk.
Organized, proactive, and product-focused mindset with the ability to manage multiple experiments, meet timelines, and maintainhigh-quality documentation.
Commitment to being fully hands-on at the bench while mentoring peers and contributing to platform and program deliverables.
Desirable Skills/Experience
Strong preference for lentiviral vectors.
Practical understanding of safety risks and mitigations for LVV including insertional mutagenesis, off-target transduction, immunogenicity, and RCL testing.
When we put unexpected teams in the same room, we fuel bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at paceand challenge perceptions. That’swhy we work, on average, a minimum of three days per week from the office. But that doesn'tmean we’renot flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and daring world.
The annual base pay for this position ranges from $118K to $178K. Our positions offer eligibility for various incentives-an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.
Date Posted
09-Oct-2026Closing Date
15-Oct-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.

